marginally significantp = 0.05
Two RCTs (n = 19 and 21, respectively) in breast cancer survivors measured disease-specific biomarkers and reported marginally significant improvements in circulating IL-6 and IGF-1 (p = 0.05 and 0.06, respectively) [ 16 ].